- 不限
- 2024-06-06 [星期四]
- 2024-06-07 [星期五]
- 2024-06-08 [星期六]
- 不限
- 沃森报告厅 Watson Auditorium
- EII 厅 Exhibition Area - II
- EIII 厅 Exhibition Area - III
- M1会议室 Meeting room - M1
- M2会议室 Meeting Room - M2
- M3会议室 Meeting Room - M3
- M4会议室 Meeing Room-M4
- M5会议室 Meeting Room - M5
- M9会议室 Meeting room - M9
2024-06-08 星期六
EII 厅 Exhibition Area - II
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 08:00-08:12 |
Role of prostate artery embolization for prostate cancer |
Justin J. Guan | Cleveland Clinic, USA |
| 08:12-08:24 |
The utilization of algorithm for the early detection of HCC |
Jia-Yun Liu | Xijing Hospital, China |
| 08:24-08:36 |
Next gen of Y90 devices and emerging clinical data on horizon |
Zhong Qian | Louisiana State University, USA |
| 08:36-08:48 |
Biomaterials and nanomedicine to assist interventional cancer therapies |
Zhuang Liu | Soochow University, China |
| 08:48-09:00 |
Challenge of Car-T therapy for advanced ovarian cancer: From bench to bed |
Yang Shen | Zhongda Hospital, Southeast University, China |
| 09:00-09:12 |
Gd-EOB-DTPA with MRI-guided microwave ablation for very early stage HCC |
Cheng-Li Li | Shandong Provincial Hospital Affiliated to Shandong First Medical University, China |
| 09:12-09:30 |
Q ＆ A |
||
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 09:30-09:42 |
Diet and Drug Resistance in Liver Cancer |
Jian-Ping Guo | First Affiliated Hospital of Sun Yat-sen University, China |
| 09:42-09:54 |
Ethanol embolization/sclerotherapy for benign lesions |
Lixin Su | The Ninth People's Hospital affiliated to Shanghai Jiao Tong University |
| 09:54-10:06 |
Management of portal hypertension in patients with HCC |
Xue-Feng Luo | West China Hospital, Sichuan University, China |
| 10:06-10:18 |
Developments in gastroduodenal stent technology |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
| 10:18-10:30 |
Effect of dendritic cells (DC) - Lymphokine-Activated killer cells (LAKs) in patients with anaplastic thyroid carcinoma combined with first-line treatment |
George Loladze | Cancer Research Center of Georgia |
| 10:30-10:42 |
Targeting intratumoral lactic acidosis (TILA)-TACE for hepatocellular carcinoma |
Kai Jin | The Second Affiliated Hospital of Zhejiang University Medical College, China |
| 10:42-11:00 |
Q ＆ A |
||
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 11:00-11:12 |
New progress of conservative surgery for uterine myoma |
Lan Zhu | Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, China. |
| 11:12-11:24 |
MR guided focused ultrasound ablation for uterine fibroids and adenomyosis |
Han Wang | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, China |
| 11:24-11:36 |
Uterine artery embolization for uterine fibroids |
Yong Jin | The Second Affiliated Hospital of Soochow University, China |
| 11:36-11:48 |
Microwave ablation of uterine fibroids and fertility protection |
Jing Zhang | Chinese PLA General Hospital, China |
| 11:48-12:00 |
Q ＆ A |
||